ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Climb Bio Inc

Climb Bio Inc (CLYM)

1.33
0.00
(0.00%)
終了 3月14日 5:00AM
0.00
0.00
(0.00%)
取引時間後: -

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
1.33
買値
1.27
売値
1.38
出来高
-
0.00 日の範囲 0.00
1.20 52 週間の範囲 5.86
時価総額
前日終値
1.33
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
462,771
発行済株式数
67,223,760
配当利回り
-
PER
-9.78
1 株当たり利益 (EPS)
-0.52
歳入
-
純利益
-35.12M

Climb Bio Inc について

Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cel... Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Climb Bio Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker CLYM. The last closing price for Climb Bio was US$1.33. Over the last year, Climb Bio shares have traded in a share price range of US$ 1.20 to US$ 5.86.

Climb Bio currently has 67,223,760 shares in issue. The market capitalisation of Climb Bio is US$89.41 million. Climb Bio has a price to earnings ratio (PE ratio) of -9.78.

CLYM 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.13-8.904109589041.461.51381.22745251.33093262CS
4-0.26-16.35220125791.591.611.23572361.43033141CS
12-0.6-31.08808290161.932.361.24627711.78139325CS
26-3.7-73.55864811135.035.861.23766172.61203852CS
52-3.7-73.55864811135.035.861.23766172.61203852CS
156-3.7-73.55864811135.035.861.23766172.61203852CS
260-3.7-73.55864811135.035.861.23766172.61203852CS

CLYM - Frequently Asked Questions (FAQ)

What is the current Climb Bio share price?
The current share price of Climb Bio is US$ 1.33
How many Climb Bio shares are in issue?
Climb Bio has 67,223,760 shares in issue
What is the market cap of Climb Bio?
The market capitalisation of Climb Bio is USD 89.41M
What is the 1 year trading range for Climb Bio share price?
Climb Bio has traded in the range of US$ 1.20 to US$ 5.86 during the past year
What is the PE ratio of Climb Bio?
The price to earnings ratio of Climb Bio is -9.78
What is the reporting currency for Climb Bio?
Climb Bio reports financial results in USD
What is the latest annual profit for Climb Bio?
The latest annual profit of Climb Bio is USD -35.12M
What is the registered address of Climb Bio?
The registered address for Climb Bio is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Climb Bio website address?
The website address for Climb Bio is climbbio.com
Which industry sector does Climb Bio operate in?
Climb Bio operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.475
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.93
(0.00%)
0
AACGATA Creativity Global
US$ 0.9463
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.06
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.475
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.93
(0.00%)
0
AACGATA Creativity Global
US$ 0.9463
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.06
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.475
(0.00%)
0
AADIAadi Bioscience Inc
US$ 1.93
(0.00%)
0
AACGATA Creativity Global
US$ 0.9463
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.06
(0.00%)
0